TD Asset Management’s Madrigal Pharmaceuticals MDGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.03M | Buy |
23,240
+1,000
| +4% | +$303K | 0.01% | 714 |
|
|
2025
Q1 | $7.37M | Sell |
22,240
-4,090
| -16% | -$1.35M | 0.01% | 709 |
|
|
2024
Q4 | $8.12M | Sell |
26,330
-11,800
| -31% | -$3.64M | 0.01% | 695 |
|
|
2024
Q3 | $8.1M | Sell |
38,130
-17,600
| -32% | -$3.74M | 0.01% | 685 |
|
|
2024
Q2 | $15.6M | Buy |
55,730
+5,400
| +11% | +$1.51M | 0.01% | 544 |
|
|
2024
Q1 | $13.4M | Buy |
50,330
+34,790
| +224% | +$9.29M | 0.01% | 570 |
|
|
2023
Q4 | $3.6M | Buy |
+15,540
| New | +$3.6M | ﹤0.01% | 828 |
|
|
2021
Q1 | – | Sell |
-4,800
| Closed | -$534K | – | 1523 |
|
|
2020
Q4 | $534K | Hold |
4,800
| – | – | ﹤0.01% | 1321 |
|
|
2020
Q3 | $570K | Buy |
4,800
+1,595
| +50% | +$189K | ﹤0.01% | 1205 |
|
|
2020
Q2 | $363K | Buy |
+3,205
| New | +$363K | ﹤0.01% | 1251 |
|
|
2019
Q3 | – | Sell |
-5,988
| Closed | -$628K | – | 1354 |
|
|
2019
Q2 | $628K | Buy |
5,988
+100
| +2% | +$10.5K | ﹤0.01% | 1144 |
|
|
2019
Q1 | $738K | Sell |
5,888
-600
| -9% | -$75.2K | ﹤0.01% | 1100 |
|
|
2018
Q4 | $731K | Sell |
6,488
-6,904
| -52% | -$778K | ﹤0.01% | 1136 |
|
|
2018
Q3 | $2.87M | Sell |
13,392
-3,408
| -20% | -$730K | ﹤0.01% | 898 |
|
|
2018
Q2 | $4.7M | Buy |
16,800
+8,600
| +105% | +$2.41M | 0.01% | 721 |
|
|
2018
Q1 | $958K | Buy |
+8,200
| New | +$958K | ﹤0.01% | 1074 |
|